
Bacterial infections cause more than 7m deaths each year – yet conventional diagnostic methods can take up to three days, delaying the right treatment and fuelling the overuse of broad-spectrum antibiotics.
Vivid Dx has developed a rapid, culture-free diagnostic platform that identifies pathogens and their antimicrobial profiles directly from clinical samples, delivering results in under three hours.
By enabling faster, targeted treatment, Vivid Dx helps reduce unnecessary antibiotic use (a key driver of antimicrobial resistance) while cutting healthcare costs, improving patient outcomes, and saving lives.